8 Nov 2017 15:03
SUPPLEMENTAL FORM 8
Â
DETAILS OF AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
Â
Â
1. KEY INFORMATION
Â
Full name of person making disclosure: | Universities Superannuation Scheme Ltd |
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: | Spire Healthcare Group PLC |
Â
2. STOCKS
Â
Class of relevant security | Product description e.g. call option | Written or purchased | Number of securities sold | price per unit | Type e.g. American, European etc. | Expiry date |
Equities | Sell |
Â
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Â
Full details should be given so that the nature of the interest or position can be fully understood: |
USSIM traded on GB00BNLPYF73, a sell trade of 500,000.00, but only 5,845.00 of the 500,000.00 order was filled yesterday. Our total holding is currently at 4,496,842.00. Â Â Â Â |
Â
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
Â
The currency of all prices and other monetary amounts should be stated.
Â
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
Â
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
Â